percutaneous electrical nerve stimulation (PENS) for refractory neuropathic pain
Last reviewed 01/2018
- percutaneous electrical nerve stimulation for refractory neuropathic
pain
- NICE support the use of this technology and state that:
- "..current evidence on the safety of percutaneous electrical nerve stimulation (PENS) for refractory neuropathic pain raises no major safety concerns and there is evidence of efficacy in the short term. Therefore this procedure may be used with normal arrangements for clinical governance, consent and audit
- patient selection and treatment using PENS for refractory neuropathic
pain should be carried out by teams specialising in pain management..."
- what is PENS?
- in PENS, 1 or more individual nerves or dermatomes are stimulated using needle probes
- a single probe with a grounding pad or pairs of fine-gauge needles are inserted into soft tissue near the targeted nerves or into the affected dermatomes
- needles are connected to a low-voltage pulse generator and an electrical current is then applied. This may generate a sensation of paraesthesia and muscle contraction
- duration of treatment varies but each session of stimulation typically
lasts between 15 and 60 minutes
- safety and adverse effects:
- NICE list exacerbation of pain, bruising and bleeding as anecdotal
adverse events
- listed theoretical adverse events as vascular damage; damage
to local nerves with sequelae, depending on which nerve was
damaged; pneumothorax; possible interaction with a cardiac
pacemaker if used above the waistline; possible epileptogenic
effect if used near the head; possible effects if used in
pregnancy; dislodgement (with loss of effect); unpleasant
paraesthesias; and local bruising or haematoma
- listed theoretical adverse events as vascular damage; damage
to local nerves with sequelae, depending on which nerve was
damaged; pneumothorax; possible interaction with a cardiac
pacemaker if used above the waistline; possible epileptogenic
effect if used near the head; possible effects if used in
pregnancy; dislodgement (with loss of effect); unpleasant
paraesthesias; and local bruising or haematoma
- NICE list exacerbation of pain, bruising and bleeding as anecdotal
adverse events
- difference between PENS and TENS (transcutaneous electrical nerve
stimulation)
- TENS is a non-invasive therapeutic option, generally used to relieve pain, which uses peripheral nerve electrical stimulation by means of electrodes placed on the skin surface at known well-tolerated intensities
- PENS, on the other hand, uses needle-like electrodes, similar to those used in acupuncture which are 1-4 cm long, located in soft tissues or muscles at the corresponding dermatomes for that local pathology
- NICE support the use of this technology and state that:
Reference: